Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition
Open Access
- 4 February 2014
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 28 (5) , 2073-2087
Abstract
Small intestine luminal nutrient sensing may be crucial for modulating physiological functions. However, its mechanism of action is incompletely understood. We used a model of enteral nutrient deprivation, or total parenteral nutrition (TPN), resulting in intestinal mucosal atrophy and decreased epithelial barrier function (EBF). We examined how a single amino acid, glutamate (GLM), modulates intestinal epithelial cell (IEC) growth and EBF. Controls were chow‐fed mice, T1 receptor‐3 (T1R3)‐knockout (KO) mice, and treatment with the metabotropic glutamate receptor (mGluR)‐5 antagonist MTEP. TPN significantly changed the amount of T1Rs, GLM receptors, and transporters, and GLM prevented these changes. GLM significantly prevented TPN‐associated intestinal atrophy (2.5‐fold increase in IEC proliferation) and was dependent on up‐regulation of the protein kinase pAkt, but independent of T1R3 and mGluR5 signaling. GLM led to a loss of EBF with TPN (60% increase in FITC‐dextran permeability, 40% decline in transepithelial resistance); via T1R3, it protected EBF, whereas mGluR5 was associated with EBF loss. GLM led to a decline in circulating glucagon‐like peptide 2 (GLP‐2) during TPN. The decline was regulated by T1R3 and mGluR5, suggesting a novel negative regulator pathway for IEC proliferation not previously described. Loss of luminal nutrients with TPN administration may widely affect intestinal taste sensing. GLM has previously unrecognized actions on IEC growth and EBF. Restoring luminal sensing via GLM could be a strategy for patients on TPN.—Xiao, W., Feng, Y., Holst, J. J., Hartmann, B., Yang, H., Teitelbaum, D. H. Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition. FASEB J . 28, 2073–2087 (2014). www.fasebj.orgKeywords
Funding Information
- Ajinomoto Pharmaceuticals
- National Institutes of Health (2R01AI‐44076‐14)
This publication has 60 references indexed in Scilit:
- Umami Receptor Activation Increases Duodenal Bicarbonate Secretion via Glucagon-Like Peptide-2 Release in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Decreased phospho-Akt signaling in a mouse model of total parenteral nutrition: a potential mechanism for the development of intestinal mucosal atrophyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and DiseaseAnnual Review of Pharmacology and Toxicology, 2010
- T1R receptors mediate mammalian sweet and umami tasteThe American Journal of Clinical Nutrition, 2009
- Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2The Journal of Physiology, 2007
- Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndromeThe American Journal of Clinical Nutrition, 2006
- Taste Receptors in the Gastrointestinal Tract. I. Bitter taste receptors and α-gustducin in the mammalian gutAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasiaPeptides, 2006
- Lack of enteral nutrition—effects on the intestinal immune systemJournal of Surgical Research, 2005
- Total parenteral nutrition-induced apoptosis in mouse intestinal epithelium: modulation by keratinocyte growth factorJournal of Surgical Research, 2003